SciClone Pharmaceuticals (Holdings) Limited

SciClone Pharmaceuticals (Holdings) Limitedverified

6600.HK

Price:

$18.72

Market Cap:

$10.68B

SciClone Pharmaceuticals (Holdings) Limited, a biopharmaceutical company, engages in the development and commercialization of pharmaceutical products in the therapeutic areas of oncology and severe infection in Mainland China and internationally. The company's proprietary product is Zadaxin, which is used for the treatment of hepatitis B and hepatitis C viruses, and certain cancers, as well as for use as an immune system enhance. Its in-licensed products include Zometa for the treatment of patients with multiple myeloma and patients with documented bone metastases from solid tumors, and hypercalcemia of malignancy; DANYELZA for the treatment of relapsed/refractory high-risk neuroblastoma; an...[Read more]

Industry

Drug Manufacturers - Specialty & Generic

IPO Date

2021-03-03

Stock Exchange

HKSE

Ticker

6600.HK

The Enterprise Value as of December 2025 (TTM) for SciClone Pharmaceuticals (Holdings) Limited (6600.HK) is 8.90B

According to SciClone Pharmaceuticals (Holdings) Limited’s latest financial reports and current stock price. The company's current Enterprise Value is 8.90B. This represents a change of 65.91% compared to the average of 5.36B of the last 4 quarters.

SciClone Pharmaceuticals (Holdings) Limited (6600.HK) Historical Enterprise Value (quarterly & annually)

How has 6600.HK Enterprise Value performed in the past?

The mean historical Enterprise Value of SciClone Pharmaceuticals (Holdings) Limited over the last ten years is 5.68B. The current 8.90B Enterprise Value has changed 15.57% with respect to the historical average. Over the past ten years (40 quarters), 6600.HK's Enterprise Value was at its highest in in the September 2020 quarter at 12.06B. The Enterprise Value was at its lowest in in the December 2021 quarter at -960220000.00.

Quarterly (TTM)
Annual

Average

5.68B

Median

5.04B

Minimum

0

Maximum

11.46B

SciClone Pharmaceuticals (Holdings) Limited (6600.HK) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of SciClone Pharmaceuticals (Holdings) Limited Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 0%

Maximum Annual Enterprise Value = 11.46B

Minimum Annual Increase = 0%

Minimum Annual Enterprise Value = 0

Quarterly (TTM)
Annual
YearEnterprise ValueChange
20235.98B45.47%
20224.11B6.37%
20213.86B-66.29%
202011.46B10.41%
201910.38B-4.23%
201810.84B6.63%
201710.16BInfinity%
201600%
201500%
201400%

SciClone Pharmaceuticals (Holdings) Limited (6600.HK) Average Enterprise Value

How has 6600.HK Enterprise Value performed in the past?

The current Enterprise Value of SciClone Pharmaceuticals (Holdings) Limited (6600.HK) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

4.65B

5-year avg

7.16B

10-year avg

5.68B

SciClone Pharmaceuticals (Holdings) Limited (6600.HK) Enterprise Value vs. Peers

How is 6600.HK’s Enterprise Value compared to its peers?

SciClone Pharmaceuticals (Holdings) Limited’s Enterprise Value is less than YiChang HEC ChangJiang Pharmaceutical Co., Ltd. (13.48B), greater than Lansen Pharmaceutical Holdings Limited (63.74M), greater than New Horizon Health Limited (4.86B), greater than Hang Chi Holdings Limited (308.96M), less than China Evergrande New Energy Vehicle Group Limited (28.35B), greater than Mega Genomics Limited (991.54M), greater than IntelliCentrics Global Holdings Ltd. (254.54M), greater than Aidigong Maternal & Child Health Limited (1.02B), greater than Pine Care Group Limited (1.69B), greater than Honliv Healthcare Management Group Company Limited (799.37M),

Build a custom stock screener for SciClone Pharmaceuticals (Holdings) Limited (6600.HK) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like SciClone Pharmaceuticals (Holdings) Limited using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

SciClone Pharmaceuticals (Holdings) Limited (6600.HK) and other stocks custom spreadsheet templates

The easiest way to analyze a company like SciClone Pharmaceuticals (Holdings) Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Enterprise Value?

How can you use the Enterprise Value?

What is SciClone Pharmaceuticals (Holdings) Limited's Enterprise Value?

What is the highest Enterprise Value for SciClone Pharmaceuticals (Holdings) Limited (6600.HK)?

What is the 3-year average Enterprise Value for SciClone Pharmaceuticals (Holdings) Limited (6600.HK)?

What is the 5-year average Enterprise Value for SciClone Pharmaceuticals (Holdings) Limited (6600.HK)?

How does the current Enterprise Value for SciClone Pharmaceuticals (Holdings) Limited (6600.HK) compare to its historical average?